Filing Details

Accession Number:
0001077183-19-000068
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-08 17:02:30
Reporting Period:
2019-05-06
Accepted Time:
2019-05-08 17:02:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454941 William Bonello 12701 Commonweatlh Drive Suite 9
Fort Myers FL 33913
Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-06 7,200 $7.52 13,935 No 4 M Direct
Common Stock Disposition 2019-05-06 7,200 $23.53 6,735 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-05-06 7,200 $0.00 79,963 $7.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
72,763 2018-04-28 2022-04-28 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $19.60 2020-03-01 2024-03-01 41,167 41,167 Direct
Common Stock Stock Option (Right to Buy) $8.03 2019-02-26 2023-02-26 80,334 80,334 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-03-01 41,167 41,167 Direct
2023-02-26 80,334 80,334 Direct
Footnotes
  1. On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
  2. On March 1, 2019, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
  3. On February 26, 2018, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.